4.3 Article

Complement activation is associated with crescent formation in IgA nephropathy

Journal

VIRCHOWS ARCHIV
Volume 477, Issue 4, Pages 565-572

Publisher

SPRINGER
DOI: 10.1007/s00428-020-02800-0

Keywords

IgA nephropathy; Crescents; Complement; Light chain

Categories

Ask authors/readers for more resources

IgA nephropathy (IgAN) is common chronic glomerulonephritis with variable prognosis, ranging from minor urinary abnormalities to end-stage renal disease. The revised Oxford classification of IgAN explains that cellular/fibrocellular crescents are associated with poor renal prognosis, proposing an extension to the MEST-C score. C3 immunofluorescent staining follows a distribution similar to IgA staining. Therefore, complement activation was reported to play a pivotal role in IgAN pathogenesis. This study included 132 IgAN patients diagnosed by renal biopsies. The clinical parameters at the time of the biopsies were obtained from patient data records. We classified the patients into C >= 1 and C0 groups, and compared clinical, light microscopic, and immunofluorescent features. In the C >= 1 group, 2 (1.5%) and 31 (23.5%) patients were assigned to C2 and C1, respectively. The remaining 99 patients (75%) were classified as C0. The C >= 1 group had lower average age and rate of hypertension, and higher score of urinary occult blood and E score. The C >= 1 group had significantly higher average immunofluorescence scores for IgA, C5b-9, mannose-associated serine protease (MASP) 1/3, MASP2, properdin, factor B, and kappa. The steroid use rate was significantly higher in the C >= 1 group. During the follow-up period of 2.90 years on average, the rate of renal dysfunction was not significantly different between groups. Crescent formation in IgAN was associated with activation of the lectin and alternative pathways. The C >= 1 group had significantly increased use of steroids, which probably caused comparable renal function during the follow-up period.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available